Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recruiting × Hemangioblastoma × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 4 1

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 602 Neoplasms 507 Prostatic Neoplasms 310 Lung Neoplasms 233 Colorectal Neoplasms 202 Motor Activity 130 Carcinoma, Non-Small-Cell Lung 114 Uterine Cervical Neoplasms 112 Head and Neck Neoplasms 109 Pancreatic Neoplasms 106 Brain Neoplasms 105 Rectal Neoplasms 101 Carcinoma, Hepatocellular 100 Stomach Neoplasms 97 Colonic Neoplasms 86 Ovarian Neoplasms 85 Esophageal Neoplasms 70 Neoplasm Metastasis 65 Multiple Myeloma 61 Urinary Bladder Neoplasms 60 Hematologic Neoplasms 60 Sarcoma 58 Melanoma 58 Glioblastoma 57 Endometrial Neoplasms 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Glioma 54 Lymphoma 53 Anxiety Disorders 52 Gastrointestinal Neoplasms 51

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05424016 2023-12-13

PRO-HEB

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting

von Hippel-Lindau Disease, Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡